ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,664.10
0.35%
S&P ASX All Technology
3,014.80
-0.10%
Brent Oil
85.625
-1.90%
US Dollar vs AUD
1.53873
0.97%
Bitcoin
60,905.19
-4.59%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. DermTech Inc (DMTK)

  7. DermTech Inc (DMTK) News

DMTK DermTech Inc

0.5988
0.0038 (0.64%)
Last Updated: 00:15:26
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
DermTech Inc DMTK NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0038 0.64% 0.5988 00:15:26
Open Price Low Price High Price Close Price Previous Close
0.5773 0.572 0.62 0.595
more quote information »

Recent News

Date Time Source Heading
19/4/202406:15BWDermTech to Explore Strategic Alternatives and Implement..
02/4/202407:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
09/3/202400:05BWDermTech Presents Research Abstracts at the 2024 American..
08/3/202412:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202412:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:17EDGAR2Form S-8 - Securities to be offered to employees in employee..
01/3/202408:53EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202408:05EDGAR2Form 8-K - Current report
01/3/202408:01BWDermTech Reports Fourth-Quarter 2023 Financial Results
14/2/202400:05BWDermTech Announces Release Date for Fourth-quarter 2023..
01/2/202408:32EDGAR2Form 8-K - Current report
01/2/202408:30BWDermTech Announces Additional Restructuring Actions to Focus..
19/1/202400:05BWDermTech Announces Positive Topline Results From a Study..
17/1/202400:05BWDermTech Simplifies the DermTech Melanoma Test (DMT) by..
10/1/202411:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202400:00BWDermTech Announces Positive Topline Results From Trust 2..
15/12/202308:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12/12/202312:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202312:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202312:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202321:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
28/11/202321:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
21/11/202321:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14/11/202321:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
08/11/202305:57PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
03/11/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202307:09EDGAR2Form 8-K - Current report
03/11/202307:01BWDermTech Reports Third-Quarter 2023 Financial Results
31/10/202320:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24/10/202320:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/10/202323:05BWDermTech Announces Release Date for Third-Quarter 2023..
23/9/202310:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202310:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/9/202306:05BWDermTech Grants New CCO Mark Aguillard Inducement Award..
19/9/202322:05BWDermTech Announces Contracts With Highmark for the..
13/9/202310:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202310:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202310:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202322:10EDGAR2Form 8-K - Current report
11/9/202322:05BWDermTech Appoints Mark Aguillard as Chief Commercial Officer
25/8/202322:05BWDermTech Announces Inducement Grants Under Nasdaq Listing..
12/8/202308:44EDGAR2Form 144 - Report of proposed sale of securities
08/8/202306:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/8/202306:37EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:07EDGAR2Form 8-K - Current report
04/8/202306:01BWDermTech Reports Second-Quarter 2023 Financial Results
19/7/202322:00BWDermTech Announces Favorable Coverage Policy With Blues Plan..
17/7/202322:00BWDermTech Announces Release Date for Second-Quarter 2023..
14/7/202310:17EDGAR2Form 144 - Report of proposed sale of securities
14/7/202306:09EDGAR2Form 8-K/A - Current report: [Amend]

Your Recent History

NASDAQ
DMTK
DermTech
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved